SAVOR-TIMI to DECLARE-TIMI: A Review on Cardiovascular Outcome Trials of Incretin-modulators and Gliflozins

por Singh, Awadhesh K., Singh, Ritu
Publicado 2019

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times

por Singh, Awadhesh K, Singh, Ritu
Publicado 2021

Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes

por Singh, Awadhesh K, Singh, Ritu, Chakraborty, Partha Pratim
Publicado 2021

Prevalence of co‐morbidities and their association with mortality in patients with COVID‐19: A systematic review and meta‐analysis

por Singh, Awadhesh K., Gillies, Clare L., Singh, Ritu, Singh, Akriti, Chudasama, Yogini, Coles, Briana, Seidu, Sam, Zaccardi, Francesco, Davies, Melanie J., Khunti, Kamlesh
Publicado 2020

Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach

por Das, Ashok Kumar, Saboo, Banshi, Chawla, Rajeev, Aravind, S. R., Rajput, Rajesh, Singh, Awadhesh K., Mukherjee, J. J., Jhingan, Ashok, Shah, Parag, Deshmukh, Vaishali, Kale, Shailaja, Jaggi, Shalini, Sridhar, G. R., Dhediya, Rajnish, Gaurav, Kumar
Publicado 2023

Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice

por Hassanein, Mohamed, Belhadj, Mohamed, Abdallah, Khalifa, Bhattacharya, Arpan D., Singh, Awadhesh K., Tayeb, Khaled, Al-Arouj, Monira, Elghweiry, Awad, Iraqi, Hinde, Nazeer, Mohamed, Jamoussi, Henda, Mnif, Mouna, Al-Madani, Abdulrazzaq, Al-Ali, Hossam, Ligthelm, Robert
Publicado 2014

COVID-19 associated mucormycosis: A Descriptive Multisite Study from India

por Gupta, Ritesh, Kesavadev, Jothydev, Krishnan, Gopika, Agarwal, Sanjay, Saboo, Banshi, Shah, Meet, Mittal, Atul, Durani, Suhail, Luthra, Atul, Singhal, Anuj, Rasheed, Muhammed, Rao, G.V.S., Tripathi, Vidit, Jha, Alka, Ghosh, Amerta, Mohan, V., Singh, Awadhesh K., Phatak, Sanjeev, Panicker, John, Bhadada, Sanjay Kumar, Joshi, Shashank, Pal, Rimesh, Mithal, Ambrish, Vikram, Naval, Misra, Anoop
Publicado 2021